TNC Desk, June 7
In a significant move towards battle against the infectious disease, All India Institute of Medical Sciences (AIIMS) is likely to commence screening of children for the clinical trial of COVID-19 vaccine from Monday.
As per information received, the clinical trial will be done for Covaxin, the India-made vaccine. In this regard, AIIMS Delhi has taken permission from Drugs Controller General of India (DCGI) and soon the trial will start.
It is to be mentioned here that the trial for Covaxin in children aged around 12-18 years started in AIIMS Patna last Tuesday following the permission received from DCGI by Bharat Biotech.